Cargando…
Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects
Background: Activation of the sympathetic nervous system is an important feature in hypertension and congestive heart failure. A strategy for directly modulating sympathetic nerve function is to reduce the biosynthesis of norepinephrine (noradrenaline) via inhibition of dopamine-β-hydroxylase (DβH)....
Autores principales: | Nunes, Teresa, Rocha, José F., Vaz-da-Silva, Manuel, Igreja, Bruno, Wright, Lyndon C., Falcão, Amílcar, Almeida, Luis, Soares-da-Silva, Patricio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585840/ https://www.ncbi.nlm.nih.gov/pubmed/21171669 http://dx.doi.org/10.2165/11586310-000000000-00000 |
Ejemplares similares
-
Effect of Food on the Pharmacokinetic Profile of Etamicastat (BIA 5-453)
por: Vaz-da-Silva, Manuel, et al.
Publicado: (2012) -
Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10‐2474: A Double‐Blind, Randomized, Placebo‐Controlled Study in Healthy Volunteers
por: Rocha, José‐Francisco, et al.
Publicado: (2021) -
Bioequivalence of Eslicarbazepine Acetate from Two Different Sources of its Active Product Ingredient in Healthy Subjects
por: Falcão, Amílcar, et al.
Publicado: (2013) -
Bioelectrical impedance analysis of body composition for the anesthetic induction dose of propofol in older patients
por: Araújo, Ana M., et al.
Publicado: (2019) -
Dopamine beta-hydroxylase deficiency
por: Senard, Jean-Michel, et al.
Publicado: (2006)